Find the right fit for you - faster
Get tailored insights about working at Progenesis in one quick step.
Progenesis Snapshot
1 OfficeLocations
At Progenesis, we believe in innovation. Our expert scientists are constantly working to improve our products through research and development. Our goal is to provide our patients with the latest, most advanced technology and information to equip them with the best tools to build healthy families. In addition to our expert staff of geneticists and laboratory personnel, our excellent support team specializes in assisting both our patients and clinicians.
Progenesis is the first company in the US to introduce Next Generation Sequencing (NGS) for Preimplantation Genetic Testing for Aneuploidy (PGT-A) and Preimplantation Genetic Testing for Monogenic disorders (PGT-M). We offer a range of products geared toward patients at all stages of family planning.
All of our services are carefully designed with the patient in mind while staying up-to-date on the most recent trends in genetics and technology. Our carrier screening panel is the most comprehensive test available on the market today. We are focused on helping patients and clinicians make informed decisions for successful and healthy pregnancies.
Our panel includes over 500 conditions to assess a patient’s risk of having a child with an inherited disorder before conception. For couples that have already begun IVF, preimplantation genetic screening and diagnosis can help select the best embryo for transfer. During pregnancy, Progenesis offers non-invasive prenatal testing as early as 10 weeks of pregnancy to evaluate the health of the fetus.
Together, our dynamic team is committed to making the IVF journey more fruitful and less stressful for our patients.
All of our services are carefully designed with the patient in mind while staying up-to-date on the most recent trends in genetics and technology. Our carrier screening panel is the most comprehensive test available on the market today. We are focused on helping patients and clinicians make informed decisions for successful and healthy pregnancies.
Our panel includes over 500 conditions to assess a patient’s risk of having a child with an inherited disorder before conception. For couples that have already begun IVF, preimplantation genetic screening and diagnosis can help select the best embryo for transfer. During pregnancy, Progenesis offers non-invasive prenatal testing as early as 10 weeks of pregnancy to evaluate the health of the fetus.
Together, our dynamic team is committed to making the IVF journey more fruitful and less stressful for our patients.
